Background: Reverse Transcriptase (RT) of immunodeficiency virus type-1 (HIV-1) remains
an essential target for new antiretroviral therapies. Non-nucleoside reverse transcriptase …

Despite almost 40 years of intensive research, there is still no curative treatment for HIV-
1/AIDS. Anti-retroviral therapy (ART) prolongs the life expectancy of HIV-1-infected …

O VIH é um retrovírus que já causou a morte de cerca de 940 mil pessoas até 2017, e
infetou mais de 36, 9 milhões no mundo, sendo o continente africano a região do globo …

The development of an effective vaccine against HIV-1 is thought to be a key component of
combating the current HIV epidemic. This study aimed to investigate viral reservoirs in the …

Depuis sa découverte dans les années 90, le virus de l'immunodéficience humaine (VIH)
représente un problème de santé publique mondial. On estime aujourd'hui qu'il a causé la …

Background and Introduction: HIV is one of the most problematic pandemics to date,
currently infecting upwards of 38 million people worldwide (“The Global HIV/AIDS …

Актуальность темы исследования По данным Всемирной организации
здравоохранения, количество лиц, живущих с хронической инфекцией, вызванной …

HIV transactivator protein (Tat) plays a pivotal role in viral replication through modulation of
cellular transcription factors and transactivation of viral genomic transcription. The effect of …

Broadly neutralising antibodies (bNAbs) are able to neutralise diverse HIV-1 strains and are
therefore important to elicit by an effective HIV-1 vaccine. bNAbs that target the V3-glycan …

As a result of future instrument discontinuation by Octapharma AB's manufacturers, this
project sought to develop a new quantitative PCR analysis method for the detection of HIV-1 …